Filter by: patients
Home > Community Treatment Reports and Side Effects > Lamivudine Treatment Report
What is Lamivudine?

Lamivudine is a nucleoside reverse transcriptase inhibitor used in the treatment of HIV infection when antiretroviral therapy is warranted; should always be used as part of a multidrug regimen (at least three antiretroviral agents).

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
HIV (Human Immunodeficiency Virus) 52 14 Efficacy_major Efficacy_moderate Efficacy_none Efficacy_cant_tell
Other 3 0
Don't know 2 0
Hepatitis B 2 1 Efficacy_major
Antiviral 1 0
Support immune health 1 0

See all 59 patients currently taking Lamivudine

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 2
Moderate
 4
Mild
 3
None
 6

Commonly reported side effects, conditions, and hospitalizations associated with Lamivudine

Diarrhea 2
Cramps in stomach 1

Reported Dosages

Frequently reported dosages based on patients currently taking Lamivudine. See all 11 dosages ►

  daily 5 mg weekly 1 mg daily 5 mg daily 10 mg daily 100 mg daily 140 mg daily 150 mg daily 200 mg daily 300 mg daily
  3 Number of Patients: 3 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 3 Number of Patients: 3 1 Number of Patients: 1 13 Number of Patients: 13 1 Number of Patients: 1 34 Number of Patients: 34  

Reported Stop Reasons

Why Patients Stopped Taking Lamivudine (multiple reasons could be selected)
Reason # Patients Percentage of patients
Doctor's advice 12   Doctor's advice: 57%
Side effects too severe 6   Side effects too severe: 29%
Did not seem to work 3   Did not seem to work: 14%
Other 3   Other: 14%
Change in health plan coverage 1   Change in health plan coverage: 5%

See all 21 patients who’ve stopped taking Lamivudine

Reported Duration See details about how long patients take this treatment ▼

Currently Taking Lamivudine

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0

Stopped Taking Lamivudine

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Lamivudine

Always
 13 87%
Usually
 0 0%
Sometimes
 0 0%
Never
 2 13%

Burden

Difficulty being on treatment

Burden of Lamivudine

Very
 2 13%
Somewhat
 2 13%
A little
 0 0%
Not at all
 11 73%

Cost

Paid out of pocket

Cost of Lamivudine

$200+
 0 0%
$100-199
 1 14%
$50-99
 2 29%
$25-49
 0 0%
< $25
 4 57%

See more information, including instructions, precautions, side effects, and interactions.

Report created on May 26, 2012.